nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accounting for Interim Safety Monitoring of an Adverse Event Upon Termination of a Clinical Trial
|
Dallas, Michael J. |
|
2008 |
|
4 |
p. 631-638 |
artikel |
2 |
A Class of Repeated Measures Concordance Correlation Coefficients
|
King, Tonya S. |
|
2007 |
|
4 |
p. 653-672 |
artikel |
3 |
A comparison of the random-effects pattern mixture model with last-observation-carried-forward(locf) analysis in longitudinal clinical trials with dropouts
|
Siddiqui, Ohidul |
|
1998 |
|
4 |
p. 545-563 |
artikel |
4 |
Adaptive survival trials
|
Rosenberger, William F. |
|
1997 |
|
4 |
p. 617-624 |
artikel |
5 |
A global model to define the behavior of partial agonists (bell-shaped dose-response inducers) in pharmacological evaluation of activity in the presence of the full agonist
|
Ghosh, Krishnendu |
|
1998 |
|
4 |
p. 645-665 |
artikel |
6 |
Agreement Between Methods of Measurement with Multiple Observations Per Individual
|
Bland, J. Martin |
|
2007 |
|
4 |
p. 571-582 |
artikel |
7 |
A logistic dose-ranging method for phase i clinical investigations trials
|
Murphy, James R. |
|
1997 |
|
4 |
p. 635-647 |
artikel |
8 |
A Method for Constructing and Estimating the RR-Memory of the QT-Interval and Its Inclusion in a Multivariate Biomarker for Torsades de Pointes Risk
|
Trost, Donald C. |
|
2008 |
|
4 |
p. 773-796 |
artikel |
9 |
Analysis and design of repeated measures in clinical trials using summary statistics
|
Ogenstad, Stephan |
|
1997 |
|
4 |
p. 593-604 |
artikel |
10 |
Analysis of 24-hour blood pressure data
|
Rodda, B. |
|
1996 |
|
4 |
p. 495-513 |
artikel |
11 |
Analytical Expressions for Combining Population Pharmacokinetic Parameters from Different Studies
|
Dokoumetzidis, Aristides |
|
2008 |
|
4 |
p. 662-676 |
artikel |
12 |
An example of using mixed models and proc mixed for longitudinal data
|
Wolfinger, Russell D. |
|
1997 |
|
4 |
p. 481-500 |
artikel |
13 |
A note on the sample size determination in two-period repeated measurements crossover design with application to clinical trials
|
Yue, Lilly Q. |
|
1998 |
|
4 |
p. 577-584 |
artikel |
14 |
A note on the small sample behavior of logistic regression in a bioassay setting
|
Nottingham, Quinton J. |
|
1998 |
|
4 |
p. 565-576 |
artikel |
15 |
An Overview on Assessing Agreement with Continuous Measurements
|
Barnhart, Huiman X. |
|
2007 |
|
4 |
p. 529-569 |
artikel |
16 |
A power study of a sequential method of p-value adjustment for correlated continuous endpoints
|
Arani, Ramin B. |
|
1998 |
|
4 |
p. 585-598 |
artikel |
17 |
Applied Mixed Models in Medicine, Second Edition, by H. Brown and R. Prescott
|
Shults, Justine |
|
2007 |
|
4 |
p. 769-773 |
artikel |
18 |
A reviewer's perspective on multiple endpoint issues in clinical trials
|
Huque, M. F. |
|
1997 |
|
4 |
p. 545-564 |
artikel |
19 |
A Review of: “Applied Regression Analysis and Other Multivariable Methods, 4th ed., by D. G. Kleinbaum, L. L. Kupper, A. Nizam, and K. E. Muller”
|
Hayden, Robert W. |
|
2008 |
|
4 |
p. 797-798 |
artikel |
20 |
A Review of: “Design and Analysis of DNA Microarray Investigations”
|
Hardin, Johanna |
|
2005 |
|
4 |
p. 747-749 |
artikel |
21 |
A Review of: “Design of Studies for Medical Research”
|
Noursalehi, Mojtaba |
|
2006 |
|
4 |
p. 573-575 |
artikel |
22 |
A Review of: “Interpreting and Reporting Clinical Trials: A Guide to the CONSORT Statement and the Principles of Randomised Controlled Trials, by A. Keech, V. Gebski, and R. Pike (eds.)”
|
Simon, Steve |
|
2008 |
|
4 |
p. 802-804 |
artikel |
23 |
A Review of: “Mixed Models: Theory and Applications”
|
Hurtado, Gerardo I. |
|
2005 |
|
4 |
p. 751-752 |
artikel |
24 |
A Review of: “New Drug Development: Design, Methodology, and Analysis, by J. R. Turner”
|
McCague, Kevin |
|
2008 |
|
4 |
p. 799-801 |
artikel |
25 |
A review of nonparametric tests for :changepoint problems, with application to a recombinant drug therapy clinical trial
|
Koziol, James A. |
|
1996 |
|
4 |
p. 425-441 |
artikel |
26 |
A Review of: “Statistics: A Guide to the Unknown”
|
Hayden, Robert W. |
|
2006 |
|
4 |
p. 577-578 |
artikel |
27 |
A Safety Monitoring Procedure for a Clinical Drug Development Program, with Application to the Assessment of a Novel COX-2 Inhibitor
|
Bolland, Kim |
|
2008 |
|
4 |
p. 737-749 |
artikel |
28 |
Assessing Individual Agreement
|
Barnhart, Huiman X. |
|
2007 |
|
4 |
p. 697-719 |
artikel |
29 |
Assessing Observer Agreement in Studies Involving Replicated Binary Observations
|
Haber, Michael |
|
2007 |
|
4 |
p. 757-766 |
artikel |
30 |
A Tolerance Interval Approach for Assessment of Agreement with Left Censored Data
|
Choudhary, Pankaj K. |
|
2007 |
|
4 |
p. 583-594 |
artikel |
31 |
A Unified Approach for Assessing Agreement for Continuous and Categorical Data
|
Lin, Lawrence |
|
2007 |
|
4 |
p. 629-652 |
artikel |
32 |
Author Index to Volume 13
|
|
|
2003 |
|
4 |
p. 807-809 |
artikel |
33 |
BIOPHARMACEUTICAL STATISTICS IN A PHARMACEUTICAL REGULATED ENVIRONMENT: PAST, PRESENT, AND FUTURE
|
Segreti, Anthony C. |
|
2002 |
|
4 |
p. 347-372 |
artikel |
34 |
Book Review
|
Mietlowski, William |
|
2004 |
|
4 |
p. 1099-1101 |
artikel |
35 |
Book Review
|
Pennello, Gene |
|
2004 |
|
4 |
p. 1103-1106 |
artikel |
36 |
Book Review
|
Holmgren, Eric |
|
2004 |
|
4 |
p. 1107-1108 |
artikel |
37 |
Clinical trial designs—made to order
|
Andersen, John S. |
|
1996 |
|
4 |
p. 515-522 |
artikel |
38 |
Clinical Trials Simulation: A Statistical Approach
|
Westfall, Peter H. |
|
2008 |
|
4 |
p. 611-630 |
artikel |
39 |
Commentary on “Accounting for Interim Safety Monitoring of an Adverse Event Upon Termination of a Clinical Trial”
|
Tsong, Yi |
|
2008 |
|
4 |
p. 639-640 |
artikel |
40 |
Commentary on “Accounting for the Interim Safety Monitoring of an Adverse Event Upon Termination of a Clinical Trial”
|
Liu, Jen-pei |
|
2008 |
|
4 |
p. 641-643 |
artikel |
41 |
Comparison of Concordance Correlation Coefficient and Coefficient of Individual Agreement in Assessing Agreement
|
Barnhart, Huiman X. |
|
2007 |
|
4 |
p. 721-738 |
artikel |
42 |
Comparison of Concordance Correlation Coefficient Estimating Approaches with Skewed Data
|
Carrasco, Josep L. |
|
2007 |
|
4 |
p. 673-684 |
artikel |
43 |
Compound Optimal Design Criteria for Nonlinear Models
|
McGree, J. M. |
|
2008 |
|
4 |
p. 646-661 |
artikel |
44 |
Conceptual and statistical issues in the validation of analytic dilution assays for pharmaceutical applications
|
Smith, Wendell C. |
|
1998 |
|
4 |
p. 509-532 |
artikel |
45 |
Crossover trials with a cumulative response
|
Walter, Stephen D. |
|
1997 |
|
4 |
p. 649-666 |
artikel |
46 |
Cumulative Statistical Power for Hierarchical Comparisons to Evaluate Two Combination Drug Doses
|
Matsukura, Tomoharu |
|
2008 |
|
4 |
p. 750-772 |
artikel |
47 |
Design of Vaccine Equivalence/Non-Inferiority Trials with Correlated Multiple Binomial Endpoints
|
Kong, L. |
|
2006 |
|
4 |
p. 555-572 |
artikel |
48 |
Editorial board
|
|
|
1998 |
|
4 |
p. 1 |
artikel |
49 |
Editorial board
|
|
|
1996 |
|
4 |
p. 1 |
artikel |
50 |
Editorial board
|
|
|
1997 |
|
4 |
p. 1 |
artikel |
51 |
Effect of delayed observations on bayesian decisions for binary data
|
Williamson, Patricia Pepple |
|
1998 |
|
4 |
p. 599-617 |
artikel |
52 |
Estimating Reliability and Generalizability from Hierarchical Biomedical Data
|
Molenberghs, Geert |
|
2007 |
|
4 |
p. 595-627 |
artikel |
53 |
Estimating Vaccine Efficacy from Outbreak Size Household Data in the Presence of Heterogeneous Transmission Probabilities
|
Davis, X. M. |
|
2006 |
|
4 |
p. 499-516 |
artikel |
54 |
Etrank:a ranking procedure for handling missing data in clinical trials:application to venlafaxine extended-release depression clinical trial
|
Entsuah, Richard |
|
1996 |
|
4 |
p. 457-475 |
artikel |
55 |
Evaluation of the Indirect Effects of a Pneumococcal Vaccine in a Community-Randomized Study
|
Moulton, L. H. |
|
2006 |
|
4 |
p. 453-462 |
artikel |
56 |
Evolution of the canda at roche
|
Rutman, Olga |
|
1997 |
|
4 |
p. 605-615 |
artikel |
57 |
Generalizability in NonGaussian Longitudinal Clinical Trial Data Based on Generalized Linear Mixed Models
|
Vangeneugden, Tony |
|
2008 |
|
4 |
p. 691-712 |
artikel |
58 |
Guest Editorial - Preventive Vaccines
|
Horne, A. D. |
|
2006 |
|
4 |
p. 399-402 |
artikel |
59 |
Guest Editors' Note
|
|
|
2005 |
|
4 |
p. 535 |
artikel |
60 |
Guest Editor's Note for the Special Issue on Assessing Agreement
|
Barnhart, Huiman X. |
|
2007 |
|
4 |
p. 525-527 |
artikel |
61 |
Industry, Government, and Academic Panel Discussion on Multiple Comparisons in a “Real” Phase Three Clinical Trial
|
Bauer, Peter |
|
2003 |
|
4 |
p. 691-701 |
artikel |
62 |
Inference and Sample Size Calculation in the Fit Assessment of Filtering Facepiece Respirators
|
Zhang, Zhiwei |
|
2008 |
|
4 |
p. 713-723 |
artikel |
63 |
Interim analyses and early termination of clinical trials
|
|
|
1997 |
|
4 |
p. 533-543 |
artikel |
64 |
Introduction
|
Westfall, Peter H. |
|
2003 |
|
4 |
p. 7-10 |
artikel |
65 |
In vitro-in vivo relationships for oral extended-release drug products
|
Mauger, David T. |
|
1997 |
|
4 |
p. 565-578 |
artikel |
66 |
JBS Referee List 2003-2004 Volume 14, Number 1-4
|
|
|
2004 |
|
4 |
p. 1-2 |
artikel |
67 |
Joint Inferences on Vaccine Efficacy Against Infection and Disease with Application to the First HIV Vaccine Efficacy Trial
|
Cai, T. |
|
2006 |
|
4 |
p. 517-538 |
artikel |
68 |
Longitudinal analyses for magnetic resonance imaging outcomes in multiple sclerosis clinical trials
|
D'yachkova, Yulia |
|
1997 |
|
4 |
p. 501-531 |
artikel |
69 |
Meta-analysis of clinical trials: a consumer's guide
|
Geller, Nancy L. |
|
1996 |
|
4 |
p. 377-394 |
artikel |
70 |
Multiple-objective optimal designs
|
Huang, Yu-Chung |
|
1998 |
|
4 |
p. 635-643 |
artikel |
71 |
Multistage Designs for Vaccine Safety Studies
|
Dragalin, V. |
|
2006 |
|
4 |
p. 539-553 |
artikel |
72 |
On Methods to Utilize HIV-RNA Data Measured by Two Different PCR Assays
|
Joshua Chen, Y. H. |
|
2008 |
|
4 |
p. 724-736 |
artikel |
73 |
On Statistical Evaluation of the Linearity in Assay Validation
|
Hsieh, Eric |
|
2008 |
|
4 |
p. 677-690 |
artikel |
74 |
On the Use of Zero-Inflated and Hurdle Models for Modeling Vaccine Adverse Event Count Data
|
Rose, C. E. |
|
2006 |
|
4 |
p. 463-481 |
artikel |
75 |
Overview of Vaccine Field Studies: Types of Effects and Designs
|
Halloran, M. E. |
|
2006 |
|
4 |
p. 415-427 |
artikel |
76 |
Patterns of Immune Response to a Vaccine or Virus as Measured by Intracellular Cytokine Staining in Flow Cytometry: Hypothesis Generation and Comparison of Groups
|
Nason, M. |
|
2006 |
|
4 |
p. 483-498 |
artikel |
77 |
PROGRESS REPORT ON THE GUIDANCE FOR INDUSTRY FOR STATISTICAL ASPECTS OF THE DESIGN, ANALYSIS, AND INTERPRETATION OF CHRONIC RODENT CARCINOGENICITY STUDIES OF PHARMACEUTICALS
|
Lin, Karl K. |
|
2000 |
|
4 |
p. 481-501 |
artikel |
78 |
Referees to Volume 13
|
|
|
2003 |
|
4 |
p. 803-805 |
artikel |
79 |
Regression Models for Method Comparison Data
|
Dunn, Graham |
|
2007 |
|
4 |
p. 739-756 |
artikel |
80 |
Relationship of whole-blood FK506 concentrations to rejection and toxicity in liver and kidney transplants
|
Hedayat, Samad |
|
1996 |
|
4 |
p. 411-424 |
artikel |
81 |
Resampling Dependent Concordance Correlation Coefficients
|
Williamson, John M. |
|
2007 |
|
4 |
p. 685-696 |
artikel |
82 |
Response to Commentary
|
|
|
2008 |
|
4 |
p. 644-645 |
artikel |
83 |
Statistical Analysis of Influenza Vaccine Lot Consistency Studies
|
Nauta, J. |
|
2006 |
|
4 |
p. 443-452 |
artikel |
84 |
Statistical applications for in vitro diagnostic tests and other medical device clinical trials
|
Lao, Chang S. |
|
1997 |
|
4 |
p. 579-591 |
artikel |
85 |
Statistical Considerations for NonInferiority/Equivalence Trials in Vaccine Development
|
Wang, W. W. B. |
|
2006 |
|
4 |
p. 429-441 |
artikel |
86 |
Statistical strategies for event rate comparisons in dental studies
|
Davies, Glenn M. |
|
1997 |
|
4 |
p. 625-634 |
artikel |
87 |
Study Design and Statistical Analysis: A Practical Guide for Clinicians, by M. H. Katz
|
Hayden, Robert W. |
|
2007 |
|
4 |
p. 767-768 |
artikel |
88 |
Subject Index to Volume 13
|
|
|
2003 |
|
4 |
p. 811-816 |
artikel |
89 |
Survival and projection analyses of the effect of radiation on beagle dogs
|
Lao, Chang S. |
|
1998 |
|
4 |
p. 619-633 |
artikel |
90 |
The cardinal features of cognitive and noncognitive dysfunction and the differential efficacy of tacrine in alzheimer's disease Patients
|
Talwalker, Sheela |
|
1996 |
|
4 |
p. 443-456 |
artikel |
91 |
The conditional binomial test revisited for clinical trials
|
Lei, Xingye |
|
1998 |
|
4 |
p. 533-543 |
artikel |
92 |
The use of generalized tests in medical research
|
Ogenstad, Stephan |
|
1998 |
|
4 |
p. 497-508 |
artikel |
93 |
The use of survival analysis techniques in evaluating the effect of long-term tacrine (cognex®) treatment on nursing home placement and mortality in patients with
|
Smith, Fraser |
|
1996 |
|
4 |
p. 395-409 |
artikel |
94 |
Uniform matrix stability study designs
|
Murphy, John R. |
|
1996 |
|
4 |
p. 477-494 |
artikel |
95 |
Using Adaptive Tests for the Analysis of Repeated Measurements
|
O'Gorman, T. W. |
|
2008 |
|
4 |
p. 595-610 |
artikel |
96 |
Vaccine Clinical Trials - A Statistical Primer
|
Mehrotra, D. V. |
|
2006 |
|
4 |
p. 403-414 |
artikel |